Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
David Christenson
David Christenson is a health care consultant and the founder and CEO of Neurocare Systems. Neurocare Systems offers clinicians state-of-the-art medical-grade LED light therapy equipment for the treatment of neurological disorders, chronic pain and anti-aging. To learn more, call (800) 900-4045 or visit www.neurocaresystems.com.